A Study of Bevacizumab in Combination With First- or Second-Line Therapy in Subjects With Treated Brain Metastases Due to Non-Squamous NSCLC (PASSPORT)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
ZACTIMA (an Anti-EGFR / Anti-VEGF Agent) Combined With Docetaxel Compared to Docetaxel in Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
First Line Chemotherapy Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Effect of Celecoxib on Survival in Patients With Advanced Non-Small Cell Lung Cancer Receiving Chemotherapy
- Status
- UNKNOWN
- Phase
- PHASE3
An Open, Randomized, Multicentre, Phase II Pilot Study
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Trial of Dose-dense Paclitaxel and Cisplatin as Neo-adjuvant Chemotherapy for Operable Stage II and IIA NSCLC
- Status
- TERMINATED
- Phase
- PHASE2
Iscar for Second Line Treatment of Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- NA
Study of XL999 in Patients With Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Neoadjuvant Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Stages IB, IIA, IIB, and IIIA/T3
- Status
- TERMINATED
- Phase
- PHASE3
Neoadjuvant Chemotherapy Plus/Minus Surgery in Non-Small-Cell Lung Cancer (NSCLC) Stage IIIA/N2
- Status
- UNKNOWN
- Phase
- PHASE3
Avastin/Docetaxel/Carboplatin in Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Feasibility Study of Pemetrexed in Combination With Cisplatin or Carboplatin as Adjuvant Treatment of Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Satraplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Gefitinib and Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Random Trial for Elderly Patients With NSCLC
- Status
- UNKNOWN
- Phase
- PHASE3
Safety Study: Combined Modality Treatment for Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Docetaxel, Irinotecan, and Carboplatin in Extensive Stage Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Safety and Pharmacokinetics of Jin Fu Kang in Comb w/Docetaxel for Patients w/Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)
- Status
- COMPLETED
- Phase
- PHASE3
Iressa Case Control Study in Japan
- Status
- COMPLETED
- Phase
- N/A